HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

REVLON NORTH AMERICA 1993 SALES FALL 5.6% TO $953.8 MIL.,

This article was originally published in The Rose Sheet

Executive Summary

REVLON NORTH AMERICA 1993 SALES FALL 5.6% TO $953.8 MIL., according to a statement of operations filed by Revlon Consumer Products with the Securities and Exchange Commission March 7. The company said the decline in North America (U.S. and Canada) sales was primarily "a result of weaker consumer demand and trade inventory reductions, the company's strategy of focusing on selected brands which resulted in lower sales volume of certain fragrances in the self-select distribution channel and several other non-recurring 1992 events, all partially offset by the positive effect of 1993 new product launches."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000239

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel